Dongfeng Honda Motor Co., Ltd. recalled some JADE cars.

Recently, Dongfeng Honda Automobile Co., Ltd. filed a recall plan with the State Administration of Market Supervision according to the requirements of the Regulations on the Management of Defective Automobile Product Recall and the Implementation Measures of the Regulations on the Management of Defective Automobile Product Recall, and decided to recall some 2017-2018 JADE cars with 1.5T engines produced from July 7, 2016 to August 10, 2018.

Due to design reasons, when some vehicles within the scope of this recall continue to drive for a short distance in a low temperature environment, the engine oil level will increase. When the engine oil level increases to a certain extent, the engine fault indicator light may light up. If the vehicles continue to run in this state, the engine may be damaged and there are potential safety hazards. Dongfeng Honda Automobile Co., Ltd. will replace the air-conditioning control unit and radiator downcomer assembly for the vehicles within the recall range free of charge, and upgrade the FI-ECU software and TCU software to curb the increase of oil level and eliminate potential safety hazards. When the recall is implemented, the engine oil and oil filter will be replaced free of charge for vehicles within the target range, and engine fuel cleaner will be added.

Dongfeng Honda Automobile Co., Ltd. will send the Notice of Defective Automobile Product Recall to the owners of vehicles within the scope of recall by registered mail, and the special sales service shop of Dongfeng Honda Automobile Co., Ltd. will notify the relevant owners by SMS or telephone. Users can call the customer service hotlines of Dongfeng Honda Automobile Co., Ltd. at 800-880-9899 (fixed line) and 400-880-6622 (mobile phone, fixed line) for consultation. Users can also visit the website of the Defective Product Management Center of the State Administration of Markets (www.dpac.gov.cn) and follow the WeChat WeChat official account for more information. In addition, you can also call the hotline of the Defective Product Management Center of the State Administration of Market Supervision: 010-59799616 to reflect the problems in the implementation of the recall or submit defects clues.

Guangqi Honda Automobile Co., Ltd. recalled some Acura CDX cars.

Recently, Guangqi Honda Automobile Co., Ltd. filed a recall plan with the State Administration of Market Supervision according to the requirements of the Regulations on the Management of Defective Automobile Product Recall and the Implementation Measures of the Regulations on the Management of Defective Automobile Product Recall, and will recall the 2017-2018 Acura CDX vehicles produced from November 2, 2015 to August 1, 2018, totaling 27.

Due to design reasons, when some vehicles within the scope of this recall are driven for a short distance in a low temperature environment for a long time, the engine oil level will increase. When the engine oil level increases to a certain extent, the engine fault indicator light may light up. If the vehicles continue to operate under the above conditions, the engine may be affected, and in extreme cases, the engine may be damaged, posing a safety hazard. Guangqi Honda Automobile Co., Ltd. will replace the upgraded air conditioning control unit and engine cooling system pipeline for the vehicles within the recall range free of charge, and upgrade the FI-ECU software to eliminate potential safety hazards. When the recall is implemented, the engine oil and oil filter will be replaced free of charge for the vehicles within the target range, and the engine fuel cleaner will be added free of charge.

Guangqi Honda Automobile Co., Ltd. will notify the relevant users by registered mail or express delivery, and the special sales service shop of Guangqi Acura Automobile will also notify the relevant users by telephone or SMS. Users can call GAC Acura customer service hotlines: 800-830-5999 (fixed-line users), 400-930-8999 (mobile phone users) and special sales service shop hotlines for consultation. Owners can log on to Guangqi Honda’s website (www.ghac.cn) to inquire about the recall information. You can also visit the website of Defective Product Management Center of the State Administration of Markets (www.dpac.gov.cn) and follow the WeChat WeChat official account for more information. In addition, you can also call the hotline of the Defective Product Management Center of the State Administration of Market Supervision: 010-59799616 to reflect the problems in the implementation of the recall or submit defects clues.

BMW Brilliance Automobile Co., Ltd. and BMW (China) Automobile Trading Co., Ltd. recalled some domestic and imported 3 series cars.

Recently, BMW Brilliance Automobile Co., Ltd. and BMW (China) Automobile Trading Co., Ltd. filed a recall plan with the State Administration of Market Supervision in accordance with the requirements of the Regulations on the Management of Defective Automobile Product Recall and the Implementation Measures for the Regulations on the Management of Defective Automobile Product Recall, and decided to recall the following vehicles from November 9, 2018, totaling 139,452 vehicles.

(1) BMW Brilliance Automobile Co., Ltd. recalled some domestic BMW Brilliance 318i, 320i and 325i cars produced between May 31, 2005 and July 24, 2011, totaling 89,309 vehicles;

(2) BMW (China) Automobile Trading Co., Ltd. recalled some imported BMW 318i, 320i, 325i, 330i, 335i and M3 cars produced between January 14th, 2005 and July 7th, 2011, totaling 50,143 vehicles.

Tin plating process is adopted for the plug coating of air conditioner blower power regulator of vehicles within the scope of this recall. With the use of the coating, wear and corrosion may occur, resulting in increased resistance. The plug with aging coating may generate heat when the air conditioner blower is used at high power, and in severe cases, it will melt and ablate the surrounding parts, which increases the risk of vehicle fire and has potential safety hazards. BMW Brilliance Automobile Co., Ltd. and BMW (China) Automobile Trading Co., Ltd. will inspect the plug of the air conditioner blower power regulator of the vehicles within the recall range free of charge, and replace the plug with a silver-plated plug if there are no signs of ablation or overheating; If overheating or ablation has occurred, in addition to replacing the plug, the damaged power regulator will be replaced to eliminate potential safety hazards.

BMW Brilliance Automobile Co., Ltd. and BMW (China) Automobile Trading Co., Ltd. will notify relevant users by registered mail. Users can call the BMW service hotline at 400-800-6666 to learn more about the recall. Users can also visit the website of the Defective Product Management Center of the State Administration of Markets (www.dpac.gov.cn) and follow the WeChat WeChat official account for more information. In addition, you can also call the hotline of the Defective Product Management Center of the State Administration of Market Supervision: 010-59799616 to reflect the problems in the implementation of the recall or submit defects clues.

Beijing Benz Automobile Co., Ltd. recalled some C-class and GLC SUV cars.

A few days ago, Beijing Benz Automobile Co., Ltd. filed a recall plan with the State Administration of Market Supervision according to the requirements of the Regulations on the Management of Defective Automobile Product Recall and the Measures for the Implementation of the Regulations on the Management of Defective Automobile Product Recall. Some C-class and GLC SUV vehicles will be recalled from now on, totaling 53 vehicles. The details are as follows:

A total of 51 C-class cars were produced from February 3, 2018 to February 23, 2018;

A total of 2 GLC SUV cars were produced on February 11, 2018.

The gas generator housing of driver airbag module assembled in some vehicles within the scope of this recall may have used unqualified materials. When a vehicle collides, the protective function of the airbag will not be guaranteed. In addition, the separated parts may enter the interior of the vehicle, hurting the people inside the vehicle, which poses a safety hazard. Beijing Benz Automobile Co., Ltd. will replace qualified driver airbags for vehicles within the recall range to eliminate potential safety hazards.

Mercedes-Benz Authorized Service Center will notify relevant users of the recall by registered mail. At the same time, relevant users can call the service hotline: 400-818-1188 (service time is Monday to Sunday, 24 hours a day) for consultation. Users can also visit the website of the Defective Product Management Center of the State Administration of Markets (www.dpac.gov.cn) and follow the WeChat WeChat official account for more information. In addition, you can also call the hotline of the Defective Product Management Center of the State Administration of Market Supervision: 010-59799616 to reflect the problems in the implementation of the recall or submit defects clues.

(The original title is "The General Administration of Market Supervision issues 4 pieces of information on automobile recalls")

On May 14th, it was reported on Wall Street that Xiaomi Automobile was asking upstream suppliers to increase the supply of spare parts, and Xiaomi SU7. Add about 80% of the orderAmong them, the number of one type of parts has increased from about 10,000 sets per month to more than 18,000 sets recently.

On May 9th, blogger @ Sun Shaojun 09 revealed that Xiaomi Auto SU7　The lock is broken by 100 thousand.

The first model of Xiaomi, SU7, was officially launched on March 28th, with a price of 215,900. There are three versions of SU7, SU7 Pro and SU7 Max. According to the official data, the car broke through 10,000 in 4 minutes, 20,000 in 7 minutes, 50,000 in 27 minutes and 88,898 units in 24 hours.

Xiaomi officially announced on May 1st that the delivery volume of Xiaomi SU7 reached 7,058 units in April (the first delivery was made on April 3rd), and the cumulative number of lock orders also reached 88,063 units.

As of the publication of IT House, Xiaomi SU7 Standard Edition is expected after locking the order.　29-32　Weekly delivery, Xiaomi SU7 Pro is expected after locking the order.　30-33　Weekly delivery, Xiaomi SU7 Max is expected after locking the order.　33-36　Weekly delivery.

In a recent interview, Yu Chengdong, CEO of Huawei’s consumer business, revealed an interesting story that he was called "Yu Dazui", which surprised many media and netizens. Yu Chengdong said frankly that the origin of this nickname is not only because he has a big mouth, but also because he dares to speak frankly and never hides.

According to Yu Chengdong, it was called "Yu Dazui" for the first time at a product launch. At that time, he boldly put forward some ideas of technological innovation and commented on his competitors without hesitation. This frank attitude impressed the media and the audience, which gave him this direct and dramatic nickname.

Yu Chengdong further stated that in today’s era of information transparency, the truth is the basis for enterprises to survive. Although his words are "bold", there is a well-thought-out truth disclosure behind them. "I think that as an era of freedom of speech, we should bravely express our ideas, rather than compromise to cater to some people." His remarks caused a heated discussion in the industry.

The competition in science and technology industry is fierce, and Yu Chengdong is deeply loved by consumers and fans for his distinctive personality and eclectic words. Recently, he talked about his views on the future development of science and technology on several platforms, which aroused widespread concern.

More than that, Yu Chengdong also shared his experience on how to adhere to the principle of truth in the complicated and changeable market environment. He said: "What customers need is transparent information and real feedback, not empty promises." His remarks not only reflect personal values, but also are regarded as an important part of corporate culture.

In this rapidly changing era of technological development, Yu Chengdong’s fearless expression has won numerous supporters. Through his own experience, he sent an important signal to the industry: only by sticking to the truth, not afraid of challenges and communicating with confidence can he be invincible in the fierce competition market.

　　At nine o’clock in the morning, the elevator in the office building is crowded with office workers who are going to be late. Nevertheless, you can easily tell the figure of interns from the crowd-no matter what they dress up, they always look childish, with glasses on their noses and bright eyes, unlike other office workers who are expressionless.

　　Interns are mostly happy and fearful. Happiness may be due to being a newcomer to the workplace. Although I don’t get any money, I can at least outline the future career life with reality instead of imagination. Fear, because be swayed by considerations of gain and loss, afraid of doing something wrong, afraid of being laughed at, afraid of poor performance and losing employment opportunities.

　　The initial internship in the workplace is very important.

　　When we enter the workplace from school, no matter what type or size of design company or enterprise we enter, we have to go through several months of internship. The experience of interns is a very important period for newcomers who have just entered the workplace. It is not only the beginning of their career, but also the beginning of learning to integrate into society and be a social person.

　　At the beginning of career, it is very important to choose a company with relatively formal management and operation, but not everyone can be satisfied. However, no matter what kind of company you enter, you must first understand the company’s system, design process, interpersonal relationship, and even the division of gangs, and learn to stand in the right position. During the internship, I will gain a lot of things that I can never understand and experience in school. The novelty at first will soon fade away, and the replacement will be confusion or sudden enlightenment. It is depression, excitement, failure and the beginning of success.

　　For those who are afraid of challenges and have weak professional knowledge, they will realize the importance of professional knowledge at the beginning of their work. Internship needs to persist in learning and innovation. For those who like challenges and progress, internship is exciting, and they will gain a sense of accomplishment while improving their design ability, gain recognition from colleagues and leaders around them, and start to succeed one after another. At the same time, they will gradually learn to get along with others and start to weave personal relationships for future development.

　　Internship is also an important period for a person’s career orientation. Some people feel that the existing company or position is not suitable, and they will choose to change jobs immediately, or even choose to change careers, while others choose to stick to it. Nowadays, many former interns have been groping in the workplace for several years, and the original rudeness has been replaced by sophistication. The original edges and corners have been smoothed by years, and the excitement after getting a little success has become a habit. What do you think when you look back on your internship? Are you glad that you insisted or regret that you didn’t choose something else?

　　Success:

　　Dare to stick to interns’ smooth "turning positive"

　　David lee is an undergraduate from xidian university. After graduation, he was well received by many tutors and interns during his internship in a foreign company in Beijing, and made a very comprehensive and rapid progress. Interns who practice together call him the "first person" among interns. Although it is a bit of a joke, david lee did make outstanding achievements during his internship.

　　In fact, Li Haohao was just an obscure "little soldier" when he first started his internship, but now he has become a master who can carry out projects independently. How did he accomplish such a gorgeous transformation?

　　In david lee’s view, internship is more than simply completing internship tasks. His company is a big school, where he can absorb all kinds of nutrition as much as possible. Facing every challenge, you can learn a lot as long as you overcome many difficulties and complete the task, and your ability in all aspects has made a qualitative leap.

　　This coincides with david lee’s mentor Zhang Haitao’s summary of him. He believes that every mentor will have certain expectations when assigning tasks to his interns, and whether they can meet or even exceed expectations is decided by the interns themselves, and it also determines how much they gain. At that time, every task assigned to david lee was quite difficult, and there were certain expectations for him, and david lee’s performance basically exceeded the expected level every time, which meant that his ability was greatly improved, and gradually accumulated to be rapid growth.

　　What david lee remembers vividly is that in 2011, under the leadership of his mentor Haitao, he was responsible for the promotion of a development project, which mainly included publicity at the booth and lectures at the sub-venue. Another big challenge. This time, david lee has to change his role as a listener and a visitor, pick up the microphone, become a narrator in front of you experienced people in the industry, experts and business owners, clearly introduce the technology and development process in a short time, and carry out lecture activities, especially facing hundreds of senior developers in the industry. "Can you Hold the audience when you are young?"

　　"In order to improve my self-confidence, at the same time, make the lecture attract the audience, and present the complicated development process and technology in a more interesting and relaxed way, I have done my homework, constantly revised the way and details of the explanation from the audience’s point of view, and repeatedly previewed it. Finally, the effect of the lecture is very good." David lee told reporters confidently.

　　There are many similar activities organized by david lee. The projects are different but the same. Every time, he sets goals, plans schedules, edits brochures, carries out the activities on site, summarizes them after the activities, and even takes charge of them from beginning to end. He also has to go to the podium to explain to different groups. Every time he faced a challenge, he chose to get up the courage to face it with all his might, and as a result, he ushered in a "brilliant rainbow" after the storm.

　　When the reporter asked Li Hao if he had taken a detour during his internship, he said sincerely that of course he did. Regarding the advice given to other interns, he stressed that we must pay attention to communication with our tutors. "When I first started my internship, I just buried myself in my work. I never took the initiative to report the progress of my work to my tutor and I wouldn’t seek advice. As a result, my tutor didn’t know whether he was working hard or not, and even questioned my work attitude and ability." Li Hao found this problem in the process of summing up experience and lessons, adjusted his working methods, reported the progress of his work to his tutor in time, and listened to their suggestions on phased work. In this way, he not only ensured that the work was carried out in the right direction, but also avoided wasting time. Looking back at the pace of progress, he himself summed up: "The stage is as big as the heart."

　　Failure:

　　"Why do you always let me do odd jobs?" Helpless to end the internship

　　Liujing, who studied in Lanzhou Business School, graduated from senior year this year and recently quit her six-month internship in an electronic product company. She complained to reporters that she worked as a merchandiser and customs broker in the company, and felt very tired and hard every day. She often worked overtime until 7: 00 or 8: 00 in the evening on weekends, and the pressure in her heart was heavier than the physical load. "At first, I felt that I had to show all the knowledge I had learned in college, and I also wanted to try my best to get any chance to stay in the company."

　　"Why do you always let me do odd jobs?" Liujing complained very much. She remembered that during her internship, she only did trivial things: sending and receiving documents, copying them to a USB flash drive, and sending them to the leadership office. Then she cleaned the office and helped the teacher bring tea and water.

　　In liujing’s view, these things have no technical content and nothing can be learned. But in the teacher’s opinion, even simple work can’t be done carefully, so she can’t be given more important work. "For example, once I bound a speech for a leader, because it was a big manuscript with many pages, I flipped through it at the end, and I didn’t say anything, but I lost a page." The most helpless thing for the teacher: "I arranged for her to take the USB flash drive to the office next door to print the document, but the document was typed out. I forgot to take it back, but I didn’t find it later, and all the important materials stored in it were lost."

　　For her carelessness, the teacher often gives liujing some advice, and occasionally accuses her. Gradually, liujing has less and less confidence in her job, often absent from work without asking for leave from the teacher, and doesn’t answer the teacher’s call. Of course, liujing, who has a sharp edge, feels excluded by colleagues and even department leaders. She always feels that her internship attitude is not correct. Two months later, she is still doing the work of sending and receiving documents and cleaning, and her work arrangement has not improved at all.

　　A busybody then deliberately told her privately that her situation would not change, and naturally she would not be left in the company, because any employee in the company would appreciate what she is doing now. As a result, Liu Jing, who was fragile and sensitive at heart, ran to the bathroom and cried bitterly, feeling that she would always be the little clerk who sent and received documents and would never be valued by the leaders. So she stopped working actively in the next internship period, and rarely actively communicated with colleagues and leaders, and hastily ended her internship for half a year.

　　"Actually, when I think about it, the original idea was a bit extreme. Now I really regret it. I gave up the opportunity to continue my internship, but now I have nowhere to find a better company for my internship." Now liujing is a little regretful. She didn’t practice in a company in a down-to-earth way. She told reporters: "I just ignored that every intern grew up step by step in a difficult situation, not a one-step process. This requires a serious and correct attitude. What I lacked was this correct attitude, which also led to my failure experience."

　　Let go of the psychological burden and get out of the internship misunderstanding.

　　Some suggestions on the internship process:

　　It is not advisable to practice for quick success and instant benefit.

　　Many people are too utilitarian when looking for an internship. If the company says it doesn’t keep people or is uncertain, it will often slack off a lot in attitude and action, which is not desirable. In fact, many companies have been secretly observing that students can stay as long as they perform well in the internship process, and companies are very willing to retain interns.

　　Small companies also make people grow.

　　Many people tend to look for big companies when they are looking for internships. They feel that they can’t learn anything from internships in small companies, and they may not be able to add points for future job hunting. However, the positions opened by big companies are limited after all. In fact, what is the content of internship is more important than where to practice. Recruiters mainly examine students’ ability and quality through their internship process.

　　Vulnerable psychology matures as soon as possible.

　　At work, many interns are psychologically fragile. College students are called the favored ones, the teachers’ favorites at school and the parents’ treasures at home, so some interns are rather delicate and lazy. However, after entering the workplace, there are time and quality requirements for work. Psychologically too fragile, they need to be strong, and many students need to mature as soon as possible because it takes too long to change from student status to workplace. We should forget the identity of students as soon as possible and complete the transformation from students to social people and then to professionals.

　　See more, listen more, think more and do more.

　　Some workplace interns are active in their work, but lack thinking, and it is easy to do things without thinking. Seeing what my colleagues around me do, I will do something like this, which will not make me make great progress. Newcomers should still watch more, listen more and talk less, and not be eager to show themselves. As interns, we should talk less, but listen more, watch more, think more and do more, and sum up the experience of our predecessors in the workplace for our own use.

　　Reporter’s note:

　　Every intern is shouting that the work is too hard, and the company doesn’t treat itself as a person. This is not their ideal company, and this is not the place where their dreams begin. However, is there anyone who is willing to think about every simple job a little further and further? Every intern is complaining that the work content is boring, which is nothing more than filling out forms, calling and sending express copies, but have you thought about it carefully, and whether there are any solutions to these work contents?

　　Internship is not about going to a famous company to do a lot of small things, but through these small things, let yourself start the transformation from school to society, let yourself have an opportunity to get in touch with and know the society, and realize your strengths and weaknesses, abilities and preferences step by step through these opportunities, so as to quickly integrate into the society when you leave campus and choose a more satisfactory job.

　　Therefore, the more significance of internship is to give you an opportunity to think, think about yourself, think about society, think about the matching degree between the two, and think about what you still lack and like. In the internship, I learned more about how to respect my teacher, how to work with all my strength, and also learned some methods and attitudes of being a person and doing things. As for the work content, it is secondary-anyone can do such small things as sending express delivery and copying things.

　　There is an old saying called "seize the opportunity when it comes", or "the opportunity only comes to those who are prepared", but it has been proved that the opportunity does not fall from the sky, but is bought by our own accumulation at all times. We should take the internship opportunity seriously, do our job well and try to "become a full member" successfully in the fastest time. (Xinbao reporter Hai Xiaoyan)

(Source: Gansu, China Network)

The latest news! The plenary session of the Provincial Admissions Committee recently reviewed and approved the "Implementation Plan for College Entrance Examination and Admission in Hebei Province in 2021". The issuance of the "Implementation Plan" marks that the comprehensive reform of college entrance examination in our province has entered the stage of landing and implementation. How to take the new college entrance examination in the first year? How to enroll? Come and get to know each other.

How to take the new college entrance examination?

What are the exam subjects?

In 2021, the college entrance examination in our province includesUnified college entrance examinationandSelective examination of academic level in ordinary high schools(hereinafter referred to as the selective examination).

Unified college entrance examination subjects

Unified college entrance examination subjects areChinese, mathematics, foreign languagesThere are three courses, among which foreign language subjects are divided into six languages, including English, Russian, Japanese, German, French and Spanish. Candidates can choose one of them to take the exam.

Unified college entrance examination questions byUnified life system of Ministry of Education.

Selective examination subjects

Optional examination subjects arePolitics, history, geography, physics, chemistry, biology.Six subjects, candidates must choose one from the two preferred subjects of history and physics, and then choose two from the four re-selected subjects of ideology, politics, geography, chemistry and biology to take the exam.

Selective examination subject questions byAutonomous life system in our province. Students in ordinary senior high schools should apply for selective examination subjects on the basis of passing the qualification examination of academic level of corresponding subjects.

How to arrange the examination time?

The exam is scheduled forJune 7-9. The examination duration of Chinese subject is 150 minutes, the examination duration of mathematics and foreign language subjects is 120 minutes, and the examination duration of each subject of selective examination subjects is 75 minutes.

The examination time of unified college entrance examination subjects is subject to the announcement of the Ministry of Education. If there is any adjustment, the examination time of selective examination subjects in our province will be adjusted accordingly.

Out of 750 points

The total score of the candidates’ college entrance examination culture consists of three scores of Chinese, mathematics and foreign languages in the unified college entrance examination and three scores of selective examinations selected by the candidates. The full score is.750Points.

Out of 150 points for each subject except the number of languages.

Unify the full marks of Chinese, mathematics and foreign languages in college entrance examination subjects.150Points, all pressOriginal achievementIncluded in the total score of candidates’ college entrance examination culture.

The full score of each elective subject is 100 points.

Full marks for each elective examination subject.100Points, among which,Preferred subjectScore pressOriginal achievementIncluded in the total score of candidates’ college entrance examination culture,Re-selected subjectsScore pressGrade assignmentAfter that, it is included in the total score of the candidates’ college entrance examination culture.

How to assign grades?

with regard toPolitics, geography, chemistry, biologyIn the four re-selected subject exams, the grade assignment is a score converted from the original grade according to the unified rules.

After the conversion, the score is 100 points, and the starting point is 30 points. Firstly, the original scores of candidates in each re-election subject are divided into five grades: A, B, C, D and E, and the proportion of people in each grade is about 15%, 35%, 35%, 13% and 2% respectively. Then, according to the principle of proportional conversion, the original scores of candidates in grades A to E are converted into five score intervals, namely, 100 ~ 86, 85 ~ 71, 70 ~ 56, 55 ~ 41 and 40 ~ 30, respectively, to obtain the scoring scores of candidates.

When the results of the college entrance examination are announced, the results of the re-selected subjects inquired by the candidates are the results after the grades are assigned, and the candidates do not need to convert themselves.

How to set the admission batch?

According to three categories

Enrollment of colleges and universities in our province byGeneral, art, sports.Three categories, respectively, batch setting, the implementation of parallel volunteer and sequential voluntary two modes.

Two new changes

According to the enrollment situation in the past two years, individual enrollment types have been fine-tuned:

First, the normal students at public expense and the students with free medical orientation will be included in the B section of the undergraduate advance approval, and they will fill in their volunteers and enroll at the same time with the national special plan, and implement the "professional (class)+school" parallel volunteer investment mode to avoid being transferred to the targeted employment areas where candidates are not satisfied.

Second, the undergraduate preparatory classes will be included in the undergraduate general approval, and the volunteers will be filled in and enrolled at the same time with the undergraduate general approval, so as to improve the volunteer satisfaction rate of the preparatory classes.

General admission batch

Ordinary admission batches are divided intoUndergraduate approval in advance, undergraduate approval, specialist approval in advance, and specialist approvalWait for four batches.

Undergraduate advance approval is divided into three sections: A, B and C, which are accepted in turn.

Undergraduate programs include general undergraduate majors, local special programs, undergraduate preparatory classes, etc., which are not included in the advance approval of undergraduate programs. Implement with "Major (class)+school"parallel volunteer model, a" major (class)+school "as a volunteer.Set up a centralized volunteering and a solicitation of volunteers, with a maximum of 96 volunteers each time.

Art admission batch

Art enrollment is divided into two batches: undergraduate advance approval and specialist advance approval.

Among them, the undergraduate advance approval is divided into three sections: A, B and C, which are accepted in turn.

Sports admission batch

Sports enrollment is divided into two batches: undergraduate advance approval and specialist advance approval.

Among them, the advance approval of undergraduate course is divided into two sections, A and B, which are accepted in turn.

How to volunteer?

Volunteer setting new changes

Implement the batch of parallel volunteer,From the school as a volunteer unit to the "major (class)+school" as a volunteer unit, that is, one "major (class)+school" as a volunteer.

Among them, ordinary candidates can fill in at most each time.96A "professional (class)+school" volunteer, art and sports candidates can fill in at most every time.70A "major (class)+school" volunteer.

The batch of sequential volunteering is still extended to the current school-based filing method.

Give priority to volunteering from a professional perspective.

By adopting the "major (class)+school" volunteer mode, candidates can give priority to choosing colleges and universities from a professional perspective and fill in their volunteers according to their own interests and specialties. Compared with the past, its advantages are mainly reflected in:One isCan better safeguard the interests of candidates. On the premise that the subjects selected by candidates are consistent with the enrollment majors (categories), candidates directly fill in the specific majors of the school and cancel the professional adjustment, thus avoiding the regret of being adjusted to dislike majors, which is conducive to the cultivation of students’ professional awareness and the display of students’ personality and specialties, and promoting students’ growth and success.The second isIt can promote the further strengthening of specialty construction in colleges and universities.The third isCan strengthen the training of talents in related fields.

Volunteer to pay attention to the requirements of the selected subjects

After the reform, the main change in voluntary reporting is the increase in the requirements for elective subjects. When candidates fill in their volunteers, they should carefully check the requirements of the selected subjects of college enrollment majors, which should meet the requirements of both the preferred subjects and the re-selected subjects.

How to enroll in colleges and universities?

How to draw the fractional line

The admission control scores of undergraduate and junior college students are defined according to the general category, art category and sports category.

Among them, the general category and sports category are divided into enrollment plans according to the combination of physics subjects and history subjects, and underlined separately;

Art enrollment continues the policy of previous years, regardless of the combination of physics subjects and history subjects, and the enrollment plan is unified and underlined.

Admission method

From 2021, the enrollment of ordinary colleges and universities will be based on the results of the unified college entrance examination and the selective examination of high school academic level, with reference to the comprehensive quality evaluation. The comprehensive quality evaluation of ordinary senior high school students serves as a reference for college enrollment. When filing, our province provides the comprehensive quality evaluation of candidates to the enrollment colleges. The specific methods of use shall be specified by the enrollment colleges in the enrollment regulations.

Composition of scores of art and sports candidates

The composition of comprehensive achievements in art and sports shall be implemented in accordance with the existing regulations of our province, specifically:

(1) Fine arts, music (including vocal music and instrumental music), dance, calligraphy and costume performance: comprehensive score = total cultural score of the college entrance examination (including policy bonus) ×0.3+ (professional score ÷ full score) ×750×0.7, and the results are rounded to three decimal places.

(2) Drama, Film and Television, broadcasting and hosting: comprehensive score = total cultural score of the college entrance examination (including policy bonus) ×0.7+ (professional score ÷ full professional score) ×750×0.3, and the result is rounded to three decimal places.

(3) Sports: comprehensive score = total cultural score of college entrance examination (including policy bonus) ×0.3+ (professional score ÷ full professional score) ×750×0.7, and the results are rounded to three decimal places.

CCTV News:Since the beginning of this year, the strength of the banking and insurance industry to support the real economy has continued to increase. From January to November this year, RMB loans increased by 15.68 trillion yuan, an increase of 589.7 billion yuan over the same period last year. On the afternoon of 20th, China Banking and Insurance Regulatory Commission held a briefing on recent key work to reply to hot issues such as the risks of small and medium-sized banks and China Banking and Insurance Regulatory Commission’s regulatory targets in 2020.

Yang Liping, chief prosecutor of China Banking and Insurance Regulatory Commission, said that only by continuously reducing the risks of financial institutions, especially small and medium-sized banks, can we further enhance our ability to serve the real economy. On the premise of finding out the risk base, small and medium-sized banks can replenish their capital by issuing common shares, capital bonds with no fixed term and introducing qualified strategic investors. At present, the risks are generally controllable.

China Banking and Insurance Regulatory Commission Chief Prosecutor Yang Liping:Find out the risk base, how much non-performing loans are, and make them real. On this basis, according to the risk situation and the size of the hole, we will replenish capital.

The support of financial institutions for small and micro enterprises has been continuously strengthened, the loan balance has been increasing, and the financing cost has gradually decreased. From January to October 2019, the average interest rate of new loans for inclusive small and micro enterprises was 6.76%, which was 0.64 percentage points lower than the average level in 2018. According to the plan, in 2020, the loans of inclusive small and micro enterprises will increase by another 2 trillion yuan, and the growth rate of loans of inclusive small and micro enterprises in five large commercial banks established diplomatic relations between workers and peasants will be above 20%.

Li Junfeng, Director of China Banking and Insurance Regulatory Commission inclusive finance Department:Further expand the coverage of credit for small and micro enterprises, and strive to increase the number of small and micro enterprises by more than 3 million next year to obtain credit support. In terms of cost reduction, we will strive to reduce the comprehensive cost of inclusive small and micro enterprise loans by 0.5 percentage points next year through hard work.

　　CCTV News:On October 27th, the Ministry of Ecology and Environment released the 2022 Annual Report on China’s Policies and Actions to Address Climate Change. According to the report, since 2021, China has actively implemented the Paris Agreement, vigorously and orderly promoted various key tasks around peak carbon dioxide emissions’s carbon neutrality goal, and achieved remarkable results.

　　At present, China has established the "1+N" policy system of carbon neutrality in peak carbon dioxide emissions, formulated the medium and long-term greenhouse gas emission control strategy, promoted the construction of the national carbon emission trading market, and worked out and implemented the national climate change adaptation strategy.

　　According to preliminary accounting, in 2021, the carbon dioxide emission per unit GDP in China will be 3.8% lower than that in 2020 and 50.8% lower than that in 2005. Non-fossil energy accounts for 16.6% of primary energy consumption, and the total installed capacity of wind power and solar power generation will reach 635 million kilowatts, which will significantly reduce the coal consumption per unit GDP, and the forest coverage rate and stock volume will achieve "double growth" for 30 consecutive years. On the first anniversary of the launch of the national carbon emission trading market, the cumulative turnover of carbon emission quotas in the carbon market was 194 million tons, with a cumulative turnover of 8.492 billion yuan.

　　It is estimated that by 2030, the carbon dioxide emission per unit GDP in China will be reduced by more than 65% compared with that in 2005, the proportion of non-fossil energy in primary energy consumption will reach about 25%, the forest stock will increase by 6 billion cubic meters compared with that in 2005, and the total installed capacity of wind power and solar power will reach more than 1.2 billion kilowatts.

　　As a giant heparin producer, () (SH603707, stock price 11 yuan, market value 17.77 billion yuan) once had a market value of more than 50 billion yuan at its peak, but at present its market value is only about 17.8 billion yuan, and the market value exceeding 30 billion yuan has disappeared in recent years.

　　In the 2023 annual report of Jianyou Co., Ltd., the total amount of monetary funds deposited abroad was 158 million yuan, but the company checked "Not applicable" for overseas assets in the annual report.

　　Such an inconspicuous detail error was keenly captured by the Shanghai Stock Exchange. In the "Regulatory Work Letter", the Shanghai Stock Exchange asked the company "the reasons for the differences before and after the disclosure of overseas assets in the annual report".

　　In fact, the overall export volume of heparin industry has been declining since 2020. Jianyou Co., Ltd. is also seeking transformation, and has acquired Meitheal Pharmaceuticals, Inc (hereinafter referred to as Meithail), an American pharmaceutical company, to expand the pharmaceutical business in the American market.

　　In 2019, Jianyou completed the consolidation of Meitheal. Meitheal is an important overseas asset of Jianyou, and it is also one of the sources of information disclosure errors in the above-mentioned annual report.

　　However, from 2019 to 2023, Meitheal lost more and earned less, with a cumulative net loss of about 100 million yuan. During the period, Meitheal also recalled the products under its name due to the wrong labeling of drug names. Recently, the public information of FDA (US Food and Drug Administration) shows that the status of several drug approvals under Meitheal’s name is "discontinued".

　　Looking back now, it is quite unreasonable for Jianyou to acquire Meitheal in some places. Including Jianyou shares had provided loans to Meitheal before its acquisition, Meitheal’s net assets were negative when it was acquired, and Meitheal’s equity was actually "exported to domestic market".

　　Image source: The reporter made drawings based on public information such as the announcement of Jianyou shares, () announcement, Sino Medical Announcement, Yuandong Biological Announcement and China Foundation Association.

　　Before Jianyou shares increased the capital of Meitheal, the original shareholder of Meitheal was a company registered in Cayman Islands. Who was the controller behind this company? Jianyou shares were not disclosed, but only expressed as "no relationship" with Jianyou shares.

　　According to the investigation by the reporter of national business daily, one of the original controllers of Meitheal emerged, that is, Zhao Jin, the former supervisor of Jianyou.

　　Meitheal was supported by Jianyou’s share loan.

　　In August 2019, Jianyou Co., Ltd. issued a foreign investment announcement, and the company increased its capital by about 95 million US dollars to obtain 83.33% equity of Meitheal83.33%

　　Jianyou Co., Ltd. said that investing in its own localized R&D, sales, quality and registration team is crucial for the company to vigorously develop the high value-added generic drug market in the United States.

　　According to the announcement, Meitheal was established in December 2016. It is a professional pharmaceutical company headquartered in Chicago, Illinois, USA, focusing on developing, manufacturing, purchasing and selling injectable drugs, which are mainly sold throughout North America. Meitheal mainly focuses on generic injections, providing customers with lower-cost brand-name drug substitutes when the patents have expired, been declared invalid or are determined not to infringe others’ patents. Meitheal has a wide range of products covering anti-infection, tumor lysis and intensive care indications, and has various presentation forms such as single-dose and multi-dose vials, ready-to-use prefilled syringes and premixed bags.

　　Image source: screenshot of Jianyou shares announcement

　　According to the disclosure of Jianyou, the original shareholders of Meitheal were LYFE Charles Limited (hereinafter referred to as LYFE) and Thomas Shea, holding 99.96% and 0.04% respectively. According to the announcement, LYFE is registered in Cayman Islands with a registered capital of 50,000 US dollars. And Mr. Thomas Shea is the CEO of Meitheal.

　　Image source: screenshot of Jianyou shares announcement

　　It is worth noting that the owner’s equity of Meitheal was even negative at that time, which was-10.17 million US dollars by the end of June 2019.

　　It is also worth noting that before the above capital increase, Jianyou shares had provided loans to Meitheal. Jianyou shares said: "Before this transaction, the target company was solely funded by LYFE, and the company provided it with a loan."

　　Image source: screenshot of Jianyou shares announcement

　　LYFE contributed $11.5 million to Meitheal in January 2017. Subsequently, LYFE did not invest any more money. Instead, Hong Kong Jianyou Industrial Co., Ltd. (hereinafter referred to as Hong Kong Jianyou), a subsidiary of Jianyou Co., Ltd., provided Meitheal with a loan of about $23 million.

　　Jianyou shares disclosed that LYFE and Thomas Shea are not related to the company in terms of property rights, business, assets, creditor’s rights and debts, and personnel.

　　Who is the actual controller of LYFE registered in Cayman Islands? Meitheal was established with a capital of more than 10 million dollars, but it was able to obtain the loan of Jianyou shares in difficult times, and then it was able to obtain the investment of Jianyou shares.

　　Jianyou shares only disclosed in its announcement that 100% shareholders of LYFE are Lyfe Capital Fund II, L.P., but did not disclose the shareholders and actual controllers behind Lyfe Capital Fund II, L.P.. With the deepening of the reporter’s investigation, the real controller behind LYFE Capital Fund II, L.P surfaced.

　　It has accumulated a loss of 100 million yuan in five years, and there have been drug recalls in the United States.

　　From 2019 to 2021, Meitheal realized operating income of about 800 million yuan, 690 million yuan and 1.04 billion yuan respectively, and realized net profit of about 7,696,600 yuan,-56.32 million yuan and 27.371 million yuan respectively.

　　Just after Meitheal realized a profit of more than 27 million yuan, in July 2022, Jianyou announced that after Hong Kong Jianyou bought 16.66% equity of Meit Heal held by LYFE with $21 million in cash, Hong Kong Jianyou would hold 99.99% equity of Meitheal16.66%

　　Image source: The reporter made drawings according to the announcement of Jianyou shares.

　　"After the company acquired Meitheal, a local American company, in October 2019, combined with Meitheal’s advantages in GPO and channel, the company’s business continued to expand in the US market and its market share continued to expand. In 2020 and 2021, Meitheal’s operating income increased substantially, and it was profitable in 2021. " Jianyou shares said.

　　Obviously, the reason for this operation is that Jianyou shares are very optimistic about the development of Meitheal. However, after Jianyou shares were consolidated with Meitheal, from the financial performance, Meitheal’s profit was true.

　　Just after the completion of the above minority acquisition, Meitheal lost nearly 80 million yuan in 2022. Throughout 2019 to 2023, Meitheal was in a state of losing more and earning less, with a cumulative loss of about 100 million yuan in five years.

　　According to the 2022 annual report of Jianyou Co., Ltd., Meitheal holds a total of 40 FDA-approved drug approvals.

　　According to the reporter’s inquiry, the latest FDA approval shows that five of the above 40 drug approvals are in discontinued market status, namely ANDA211003 calcium levofolinate injection, ANDA077096 carboplatin injection, ANDA206190 cytarabine injection, ANDA201166 Topotecan hydrochloride injection and ANDA206189 cytarabine injection.

　　Image source: FDA official website screenshot

　　It is worth noting that Meitheal once had a drug recall in the United States. According to the FDA official website, in January, 2021, Meitheal recalled the drug due to an error in the drug label.

　　Image source: FDA official website screenshot

　　According to official website information of FDA, Meitheal announced that it voluntarily recalled a batch of Cisatracurium Besylate (atracurium benzenesulfonate) injection. The decision to recall the product was made after receiving a product complaint. The complaint showed that a part of the carton with batch number C11507A was labeled with Cisatracurium Besylate injection, with 10 bottles in each box, of which 10 bottles were wrongly labeled as Phenylephrine Hydrochloride (phenylephrine hydrochloride) injection.

　　In this regard, the reporter of national business daily sent an Interview Letter to Jianyou Co., Ltd. on the reasons for the suspension of the above-mentioned drugs and the reasons for the drug recall. Jianyou shares replied to the interview that the company formulated different product strategies according to different markets. Product strategies will be different in different markets in different periods. The product update iteration in the pharmaceutical market is very normal, and there are countless such cases in major pharmaceutical companies in the United States, such as PFIZER and SANDOZ. At the same time, Jianyou shares also provided reporters with screenshots of recent discontinued products of PFIZER and SANDOZ.

　　Regarding the drug recall, Jianyou Co., Ltd. said: "The company did have this recall. The specific recall situation and reasons can be found on the official website of the US FDA. The incident is not important and did not meet the disclosure standards."

　　Meitheal’s shareholders are actually "exporting to domestic sales"

　　"Through the acquisition of Meitheal, the company’s R&D products can carry out marketing and order acquisition in advance in the R&D stage, so that the company’s products can complete the preparatory work for listing and sales more quickly, and expand the profit period and space." Jianyou Co., Ltd. once described the reason for investing in Meitheal when it first increased its capital.

　　However, as a matter of fact, Meitheal didn’t bring profit expansion to Jianyou, on the contrary, it also caused a big loss.

　　Image source: The reporter made drawings according to the announcement of Jianyou shares.

　　As for LYFE, the original shareholder of Meitheal, Jianyou shares only disclosed that its shareholder was Lyfe Capital Fund II, and L.P. was gone.

　　It is worth noting that the main body of LYFE Capital’s WeChat WeChat official account is Zhouling Private Equity Fund Management (Shanghai) Co., Ltd. (hereinafter referred to as Zhouling Private Equity). Meitheal is listed as one of the projects invested by Zhouling Private Equity official website.

　　Image source: Zhouling Private Equity official website screenshot

　　Zhouling Private Equity was established in April 2015, and its legal representative is Zhao Jin. According to the relevant resume published by China Fund Industry Association, Zhao Jin once worked for Morit Group, Weiwu Capital and other companies.

　　Image source: screenshot of China Fund Industry Association

　　The reporter noticed that Sino Medical (SH688108, share price of 8.46 yuan, market value of 3.5 billion yuan) also involved in the IPO process related to the upper-level equity structure of LYFE Capital Fund II, L.P, which provided an answer to solve this problem.

　　At that time, the exchange asked whether the equity of the transferee issuer, such as Sino Medical, LYFE Capital set up by Jifeng Capital, a domestic investment institution, was in compliance with foreign exchange management laws and regulations, and whether there was a potential risk that the issuer would bear civil and criminal liability or be punished by administrative punishment.

　　In September 2019, when Sano Medical responded to the inquiry, it said that according to the information provided by LYFE Capital, as of the date of issuing the reply report, the limited partners of LYFE Capital Fund II, L.P were mainly overseas professional parent funds, management parent funds, family funds, insurance funds and equity investment funds.

　　Image source: screenshot of Sino Medical Announcement

　　The upper level of LYFE Capital Fund II, L.P includes limited partners and general partners, and who are these limited partners behind the scenes is not disclosed by Sino Medical.

　　However, for the general partner, Sino Medical has given a clear shareholding path. The general partner of LYFE Capital Fund II, L.P is Lyfe Capital Management Limited (BVI), and this company is 100% controlled by Shanghai Jirong Investment Consulting Partnership (Limited Partnership), and the general partner of Shanghai Jirong is Jiaxing Jifeng Equity Investment Management Co., Ltd. (hereinafter referred to as Jiaxing Jifeng). Natural persons Zhao Jin and Yu Zhengkun jointly controlled Jirong in Shanghai and Jifeng in Jiaxing.

　　In other words, in that year, China enterprises actually controlled Meitheal, and the actual controllers behind them were Zhao Jin and Yu Zhengkun. Jianyou’s investment in Meitheal is similar to the operation method of "exporting to domestic sales".

　　One of the original actual controllers of Meitheal is a former supervisor of Jianyou.

　　From the common sense, the financial strength, medical industry experience and management ability of Jianyou shares are better than that of a private investment fund. Then, why did Jianyou lend money to Meitheal, and then spent a lot of money to buy it, instead of directly operating and setting up an American subsidiary?

　　According to the reporter’s investigation, many evidences show that Zhao Jin, one of the actual controllers of LYFE Capital Fund II, L.P, used to be the supervisor of Jianyou.

　　According to the prospectus of Jianyou Co., Ltd. (the declaration draft was submitted on March 15th, 2016), there was a supervisor named Zhao Jin within the reporting period. According to the introduction of Jianyou Co., Ltd., its former supervisor Zhao Jin was nominated by Weiwu (Chengdu) Biotechnology Venture Capital Co., Ltd. [hereinafter referred to as Weiwu (Chengdu)].

　　In August 2015, Jianyou Co., Ltd. held an extraordinary general meeting of shareholders, and Zhao Jin no longer served as the supervisor of Jianyou Co., Ltd..

　　According to the prospectus of Jianyou, its former supervisor, Zhao Jin, is also a director of Hanerxi (Beijing) Technology Co., Ltd. and Shanghai Jingfeng Pharmaceutical Co., Ltd.. In addition to this information, Jianyou shares did not introduce the former supervisor in detail.

　　Image source: screenshot of Jianyou shares prospectus

　　According to Jianyou, JEF, Generic and Weiwei (Chengdu) are funds managed by VIVO Ventures, holding 3.0007%, 2.2506% and 0.2813% of the total share capital of Jianyou respectively. JEF, Generic and Weiwu (Chengdu) managed by VIVO Ventures hold 5.5326% of the shares of Jianyou.

　　Image source: screenshot of Jianyou shares prospectus

　　It is worth noting that the Chinese translation of VIVO Ventures is Weiwu Venture Capital.

　　At that time, Shanghai Jingfeng Pharmaceutical Co., Ltd., the enterprise of which Zhao Jin was a director, is now called Shanghai Jingfeng Pharmaceutical Co., Ltd., which is a subsidiary of listed company *ST Jingfeng (SZ000908, share price 1.18 yuan, market value 1.038 billion yuan). According to the announcement of *ST Jingfeng, Zhao Jin used to be a consultant of Morit, and now he is the managing partner of Vivo Ventures, and he is the supervisor of Jianyou Co., Ltd., and the chairman of Hanerxi (Beijing) Technology Co., Ltd.

　　According to the resume of Zhouling Private Equity Zhao Jin disclosed by the Fund Industry Association, Zhao Jin also worked as a senior consultant in Molit Group and a managing partner in Weiwu Capital. Then, is it a coincidence that Zhao Jin disclosed by *ST Jingfeng worked in Molit and Vivo Ventures and that Zhao Jin disclosed by China Fund Industry Association worked in Molit Group and Weiwu Capital?

　　Image source: *ST Jingfeng announcement screenshot

　　On the other hand, Zhao Jin disclosed by *ST Jingfeng was the chairman of Hanerchi (Beijing) Technology Co., Ltd., which provided important clues.

　　In April 2019, Yuandong Bio (SH688513, share price of 30.5 yuan, market value of 5.384 billion yuan) was disclosed in its prospectus, and its director Zhao Jin also served as the chairman of Hanerxi (Beijing) Technology Co., Ltd. At the same time, Yuandong Bio provided a detailed resume of Zhao Jin, and Zhao Jin has worked in many companies. Among them, in Jiaxing Jifeng, Zhao Jin holds 50% of the shares and serves as executive director and manager; In Shanghai Jirong, Zhao Jin holds 40% of the property and acts as the appointed representative of the executive partner.

　　Image source: Screenshot of Yuandong Biological Announcement

　　At this point, the answer is clear. Zhao Jin, the former supervisor of Jianyou Co., Ltd., is one of the original actual controllers of Meitheal.

　　As to who is the ultimate actual controller of LYFE, Jianyou Company stated in an interview letter to the reporter of national business daily that according to the announcement of Jianyou Company’s Foreign Investment in 2019 (announcementNo.: 2019-055), the shareholder of LYFE is LYFE Capital Fund II, L.P, which holds 100% equity of Lyfe. According to the public information on the Internet, LYFE Capital Fund II, L.P belongs to LYFE CAPITAL, and its founder and managing partner is Zhao Jin. Therefore, the ultimate actual controller of LYFE is Zhao Jin.

　　Regarding the question "Is Zhao Jin, your supervisor in Si Qian, one of the former actual controllers of Meitheal?" asked in the Interview Letter. If so, did any other directors of your company participate in Meitheal’s previous shareholding? If not, can your company provide corresponding reasons? " Jianyou shares replied: "Zhao Jin, the former supervisor of the company, was appointed by VIVO, an early shareholder of the company (at that time, Zhao Jin was a global partner of VIVO), and Zhao Jin became a director of Meitheal as a global partner of LYFE. There are no other directors in the company who participate in Meitheal’s shareholding. "

　　In addition, the reporter also issued an "Interview Letter" to Zhouling Private Equity on related issues, but as of press time, no response was received from the other party.

　　To sort out the timeline, the operations of Jianyou and Zhao Jin about Meitheal are as follows:

　　In April 2015, Zhouling Private Equity was established, with Zhao Jin as the legal representative.

　　In August 2015, Zhao Jin ceased to be the supervisor of Jianyou.

　　In December 2016, Meitheal was established, and Zhao Jin, as one of the actual controllers, was controlled by Lyfe (registered capital of US$ 50,000) which was finally established in Cayman Islands through a number of companies.

　　In January 2017, LYFE contributed $11.5 million to Meitheal.

　　From 2018 to the first half of 2019, Jianyou shares borrowed $23 million from Meitheal.

　　In October 2019, Jianyou Co., Ltd. increased its capital by about US$ 100 million to obtain 83.33% equity.

　　In 2021, Meitheal achieved a profit of 27.371 million yuan.

　　In the second half of 2022, Jianyou shares purchased 16.66% equity of Meit Heal held by LYFE in cash of 21 million US dollars.

　　In 2022, Meitheal lost nearly 80 million yuan.

　　In 2023, Meitheal lost RMB 2,538,200.

Article 22 An invention or utility model for which a patent right is granted shall be novel, creative and practical.
Novelty means that no identical invention or utility model has been published in domestic and foreign publications, used in China or known to the public in other ways before the application date, and no identical invention or utility model has been applied to the patent administration department of the State Council by others and recorded in the patent application documents published after the application date.
Creativity means that compared with the existing technology before the filing date, the invention has outstanding substantive features and remarkable progress, and the utility model has substantive features and progress.
Practicality means that the invention or utility model can be manufactured or used and can produce positive effects.
[Interpretation] This article provides the essential requirements for inventions and utility models for which patents are granted.
1. According to the provisions of this article, inventions and utility models granted patent rights must be novel, creative and practical, which is commonly called the "three characteristics" of patents. This is a norm generally adopted by patent laws in various countries, and it is also a norm confirmed by the Agreement on Trade-related Aspects of Intellectual Property Rights (TRIPS) of the World Trade Organization.
Second, the second paragraph of this article defines the meaning of "novelty", that is, no identical invention or utility model has been published in domestic and foreign publications before the filing date, used publicly in China or known to the public in other ways, and no identical invention or utility model has been filed with the patent administration department of the State Council by others and recorded in the patent application documents published after the filing date. Includes three meanings:
1. The time limit for judging whether there is novelty is based on the filing date of the patent application. This is also the standard stipulated in the patent laws of most countries in the world. According to the relevant provisions of this law, the date when the patent administrative department of the State Council receives the patent application documents is the filing date. If the application documents are mailed, the postmark date sent shall be the application date. Where priority is enjoyed, it refers to the priority date. Inventions and utility models for which patents are applied are new technologies, that is, they are novel, as long as they are not available in the prior art or are not known to the public. Existing technology refers to the technical content that the public can know before the application date. The technical content in a confidential state is not known to the public, so it does not belong to the existing technology.
2. To judge whether it is novel, whether the invention or utility model for which the patent is applied has been made public and become known technology shall prevail. Where the same invention or utility model has not been publicly published in domestic and foreign publications, publicly used in China or known to the public in other ways before the filing date, it meets the requirements of novelty. The "same invention or utility model" mentioned here means that the technical fields and purposes are the same, the technical solutions are essentially the same, and the expected effects are the same. The "publicity" mentioned in this article includes: (1) publication publicity. Refers to the fact that the same invention has been recorded in official publications. The geographical scope of publication is the whole world, including both domestic and foreign countries. Before the filing date, as long as any publication in the world has published the same invention and creation, the invention and creation is not novel. Publications include all kinds of patent documents, magazines, books, academic papers, textbooks, technical manuals, etc., as well as all kinds of microfilms, films, photographic negatives, tapes, records, CDs, etc. made by means of electricity, light and photography. Publications are not limited by geographical location, language or acquisition method, nor by age. For some publications marked with the words "internal publications", if confidentiality is required within a specific scope, they are not public publications. (2) Use publicity,It refers to the disclosure of the technology to the public due to the application of this technology, such as the manufacture, sale, use, public display and performance of new products. The scope of public use is limited to China. (3) otherwise known to the public. This mainly refers to other public ways that can be known to the public. Including oral publicity, such as reports, seminars, radio or television broadcasts, etc., which can make the public know the technical content. The scope of this public way is also limited to China.
3. Whether the same invention or utility model has been filed by others and recorded in the patent document, which is customarily called "conflicting application". Since only one patent right can be granted for an invention-creation, if someone else has filed an application for the same invention or utility model with the patent administration department of the State Council before the filing date, and it is recorded in the patent application documents published after the filing date, that is, in case of conflicting application, in order to avoid repeated authorization of the same invention or utility model patent application, the invention or utility model applied for first is regarded as the existing technology of the invention or utility model applied for later, and the latter application is not novel.
Third, the third paragraph of this article stipulates the meaning of "creativity", that is, compared with the existing technology before the filing date, the invention has outstanding substantive characteristics and remarkable progress, and the utility model has substantive characteristics and progress. The "existing technology" mentioned here refers to the technology that was publicly published in domestic and foreign publications, publicly used in China or known to the public in other ways before the application date, that is, the existing technology.
1. To judge whether an invention for which a patent is applied meets the criteria of creativity is whether the invention has "outstanding substantive characteristics" and "remarkable progress". The "outstanding substantive features" mentioned here means that the invention has obvious essential differences compared with the prior art, which is not obvious to the ordinary technical personnel in the technical field to which the invention belongs. He cannot directly obtain all the necessary technical features of the invention from the prior art, nor can he obtain them through logical analysis, reasoning or experiment. If the invention can be obtained in the above way, the invention does not have outstanding substantive characteristics. The "remarkable progress" mentioned here means that from the technical effect of the invention, it has made great progress compared with the existing technology. Including: (1) the invention has solved the technical problems that people have been eager to solve, but they have never been successful; (2) The invention overcame the technical prejudice; (3) The invention has achieved unexpected technical effects; (4) The invention was a commercial success.
2. To judge whether a utility model for which a patent is applied meets the creative standards, the requirements are lower than those for invention patents, as long as the utility model has substantial characteristics and progress, and it is not required to be "prominent" or "remarkable".
Four, the fourth paragraph of this article defines the meaning of "practicality", which means that the invention or utility model can be manufactured or used, and can produce positive effects. Includes the following meanings:
1. It can be manufactured. As a technical scheme of invention or utility model, it should be achievable, that is, if the purpose of the invention is to manufacture a product, then the product must be manufactured according to the technical scheme of the invention.
2. be able to use it. As an invention or utility model, the technical scheme must be able to be implemented. If the invention is a technological method, it should be used in industrial production.
3. It can produce positive effects. Compared with the prior art, the economic, technical and social effects of the invention or utility model should be positive and beneficial. Inventions or utility models that are obviously useless, divorced from social needs, seriously pollute the environment, seriously waste energy or resources, and harm personal health are not practical.
4. It must be reproducible. As a technical scheme, the invention or utility model should be realized repeatedly. That is, technicians in the technical field can repeatedly implement the technical scheme adopted in the patent application to achieve its purpose according to the disclosed technical content. If it is a product, it should be able to be manufactured repeatedly; if it is a method, it should be able to be used repeatedly.

Article 23. The design for which the patent right is granted shall be different from or similar to the design that has been publicly published in domestic and foreign publications or publicly used in China before the filing date, and shall not conflict with the legal rights previously obtained by others.
[Interpretation] This article is about the requirements for granting a patent right to a design.
First, the design should be novel. That is, it is different from and not similar to the design that has been published in domestic and foreign publications or used publicly in China before the application date. The scope of its publication is domestic and foreign, and the scope of its public use is domestic. The "public use" mentioned here means that there is no identical physical object for public sale or use before the application date. Therefore, in terms of novelty, it is the same as the standard of invention and utility model.
Second, the design should be creative. That is, it is not the same as or similar to the existing design. "Different" here means different products and different designs. Different products mean that the uses and functions of products are not exactly the same. Different designs mean different shapes, patterns and colors. It should be pointed out that the same design, when used in different products, should not be considered as the same appearance design.
Three, shall not conflict with the legal rights obtained by others in advance. Here, "the legal rights obtained in advance" refers to the legal rights that others have obtained before the designer applies for a patent. This prior right mainly refers to: trademark right, copyright (mainly refers to art works), portrait right and so on. Because design refers to a new design that is aesthetically pleasing to the shape, pattern, color or their combination of products and is suitable for industrial application, it is easy to conflict with trademark rights, copyright and other rights. Therefore, legal provisions shall not conflict with these rights. That is, if someone else has obtained the above legal rights in advance, the applicant for a patent for design shall not obtain a patent right for the design of the product with these trademarks and works of art. This provision is a new addition to this revision of the Patent Law, with the purpose of avoiding conflicts of rights, causing disputes and harming the interests of those who have previously obtained legal rights.

Article 24 An invention-creation applying for a patent shall not lose its novelty in any of the following circumstances within six months before the date of filing:
(1) It was exhibited for the first time at an international exhibition sponsored or recognized by the China Municipal Government;
(2) It was first published at a specified academic or technical conference;
(three) others disclose the contents of the applicant without the consent of the applicant.
[Interpretation] This article is about the exception that the disclosure of inventions and creations does not lose novelty.
1. According to the provisions of Article 22 of this Law on the novelty of inventions and utility models, it is a basic principle that an invention for which a patent is applied will lose its novelty and cannot be patented if it has been made public before the date of application. But this basic principle is not absolute, and there are exceptions. The patent laws of many countries stipulate that the invention-creation can be disclosed without losing novelty within a certain period before the application date, that is, the so-called disclosure without losing novelty. This article is the patent law of our country’s disclosure of not losing novelty.
2. The time limit for publication without loss of novelty shall be within six months before the date of filing. This period is also called grace period, that is, within six months before the date of application, the application will not lose its novelty if the circumstances stipulated in this law occur. If you file a patent application after this time limit, it will no longer be novel and should not be granted a patent right.
Three, no loss of novelty, the provisions of this article are three:
1. It was exhibited for the first time at an international exhibition sponsored or recognized by the government of China. Including two meanings: First, it must be an international exhibition sponsored or recognized by the China government. International exhibitions hosted by the government of China include international exhibitions hosted by various departments in the State Council or the State Council or organized by other organs or local governments with the approval of the State Council. International exhibitions recognized by China government are those held at home and abroad, which are not held by China government, but are recognized by China government. Second, it must be an international exhibition, that is, besides the products of the host country, there should also be exhibits from foreign countries. Inventions and creations exhibited in international exhibitions that are not sponsored by the China government or recognized by the China government will no longer be novel.
2. It was first published at a specified academic conference or technical conference. The "academic conference or technical conference" mentioned here has certain restrictions and must be "prescribed" with a certain scale and specifications. According to the detailed rules for the implementation of the Patent Law, it refers to an academic conference or technical conference organized by the relevant competent authorities in the State Council or national academic organizations. It does not include academic conferences or technical conferences organized by ministries or commissions of the State Council or national societies. Inventions and creations published for the first time at academic conferences or technical conferences that meet the above requirements shall not lose their novelty.
3. Others disclose the contents without the consent of the applicant. That is, the disclosure of others against the applicant’s original intention. The ways for others to disclose the contents of their inventions and creations without the consent of the applicant may include: others disclose the contents of the applicant’s inventions and creations without complying with the express or implied confidentiality obligations; Others use threats, fraud, theft, espionage and other improper means to learn the content of the invention and creation from the inventor or any other person who has been told by him and then make it public. The disclosure of these two cases is against the applicant’s original intention and is illegal.

Article 25 No patent right shall be granted for the following items:
(1) scientific discoveries;
(2) Rules and methods of intellectual activities;
(3) Methods of diagnosis and treatment of diseases;
(4) Species of animals and plants;
(5) substances obtained by nuclear transformation.
A patent right may be granted to the production method of the products listed in Item (4) of the preceding paragraph in accordance with the provisions of this Law.
[Interpretation] This article is about the provisions on the results of intellectual activities that do not grant patent rights.
First, the purpose of establishing a patent system is to protect the achievements of intellectual activities within the legal scope. Inventions and creations that are novel, creative and practical, and meet other conditions stipulated in the patent law, belong to intellectual achievements protected by patents, and can be patented according to law. At the same time, according to the provisions of this article, the achievements of the following kinds of intellectual activities do not belong to the scope of patent protection and no patent right shall be granted:
1. Scientific discovery. It refers to the discovery and understanding of unknown substances, phenomena, changing processes, their characteristics and laws that have objectively existed in nature. These inventions and understandings are not a technical solution in themselves, not inventions in the sense of patent law, and cannot be directly implemented to solve specific technical problems in a certain field, so they cannot be granted patent rights.
2. Rules and methods of intellectual activities. It refers to people’s thinking movement, which is an abstract thing and a means or process for people’s brain to carry out spiritual and intelligent activities. It only guides people to think, judge and remember the information they express, and it does not need to adopt technical means or abide by the laws of nature, and it does not have technical characteristics, so it cannot be granted a patent right. For example, traffic rules, dictionary arrangement methods, information retrieval methods, speed algorithms or formulas, rules and methods of various games and entertainment, and competition rules cannot be patented.
3. Diagnosis and treatment of diseases. It refers to the direct implementation of living human beings or animals for the purpose of treating diseases, which cannot be monopolized by a few people because it involves human health. The "diagnosis method of disease" mentioned here refers to the whole process of identifying, studying and determining the cause or focus state of living human or animal. The "treatment of diseases" mentioned here refers to the process of blocking, alleviating or eliminating the cause or focus in order to restore or obtain health for living human beings or animals. This kind of treatment or diagnosis method cannot be manufactured or used in industry, and it is not practical, so it cannot be patented. For example, ultrasonic diagnosis, acupuncture, anesthesia, massage and other treatment methods, surgical methods and so on. The TRIPS agreement also stipulates that members can exclude diagnostic methods, therapeutic methods and surgical methods for treating humans or animals from patentability.
4. Animal and plant varieties. Animal and plant varieties refer to new varieties of animals and plants cultivated by biological methods. Animals and plants are living objects, naturally generated, products of nature, not created by people, and cannot be produced by industrial methods, so they do not have creativity and usability in the sense of patent law, so they cannot be granted patent rights. However, animal and plant varieties can be protected by laws other than the patent law. In this regard, the TRIPS agreement stipulates that members should protect new plant varieties by patent system or effective special system, or by any combination system. For the protection of new plant varieties, many countries in the world have also formulated corresponding laws and regulations. In 1997, the State Council promulgated the Regulations on the Protection of New Plant Varieties in People’s Republic of China (PRC), which stipulated the definition of new plant varieties, the content and ownership of variety rights, and protected new plant varieties that met the regulations.
5. Substances obtained by nuclear transformation. Mainly refers to the use of accelerators, reactors and other nuclear reaction devices, through nuclear fission, nuclear fusion and other methods to obtain elements or compounds. Because the substances obtained by nuclear transformation are related to the great interests of the country’s economy, national defense, scientific research and public life, and are related to national security, it is not suitable for publicity, and most countries do not grant patents to such substances.
2. Patents may be granted for the production methods of animal and plant varieties in accordance with the provisions of this Law. The "production method" mentioned here refers to non-biological methods, excluding mainly biological methods for producing animals and plants. This kind of method can be granted a patent right because of the intervention of technical elements and the main control or decisive role in the ultimate goal or effect. Patents can be obtained for microorganisms and microbial methods.
        

CCTV News:On July 25th, the Information Office of Nanjing Municipal People’s Government held the fifth news conference on the prevention and control of COVID-19 epidemic in Nanjing.

Yang Dasuo, deputy director of Nanjing Health and Health Commission, introduced the latest situation of epidemic prevention and control in Nanjing:

First, the new cases. July 24, 2021 0— — At 24: 00, there were 2 new confirmed cases (all common types) in COVID-19 and 2 new asymptomatic infected cases. Among these 4 cases, Jiangning, Lishui, Jianye and Gaochun each had one case. Up to now, there are 37 confirmed cases in Nanjing (including 14 mild cases and 23 common cases), and there are 20 asymptomatic infections in Nanjing. The relevant information and trajectories of newly confirmed cases and asymptomatic infected persons have been published through WeChat WeChat official account and Weibo such as "Nanjing Publishing" and "Healthy Nanjing".

Second, the medical treatment work. Up to now, 37 confirmed cases have been treated in Tangshan Hospital of Nanjing Second Hospital (Nanjing Public Health Medical Center), and their vital signs are stable. At present, 20 asymptomatic infected people are also in centralized isolation and medical management in Tangshan Campus of Nanjing Second Hospital.

III. Delineation of risk levels. According to the national and provincial requirements for accurate prevention and control of COVID-19 epidemic, the epidemic risk level in some areas of Nanjing has been adjusted since July 25, 2021. Since July 25, 2021, the building area where Wutai Building Materials Store is located at the intersection of provincial road 239 and Yaoding Road in Gaochun District of Nanjing has been adjusted from a low-risk area to a medium-risk area. The risk levels in other regions remain unchanged. From July 25th, 2021, No.26 Suojie, Nanyuan Street, jianye district was changed from a low-risk area to a medium-risk area. The risk levels in other regions remain unchanged. From July 25th, 2021, No.388 Xinling Road, Maoting Community, Lukou Street (medium risk), Shinian Village, Lukou Street (adjusted from medium risk to high risk). The risk levels in other regions remain unchanged. Since July 25, 2021, Xiangzhangyuan in Vanke City, Yongyang Street, Lishui District has been adjusted from a low-risk area to a medium-risk area. The risk levels in other regions remain unchanged.

Close contacts and sub-close contacts with positive people on the same flight must be centralized isolated.

Explanation: that is, if there is a case of positive infection or close contact and sub-close contact of positive infection on a plane, all the people on the same plane should be isolated.

On or after July 10, if there is a history of airport travel in and out of Hong Kong and a record of ticket purchase, standardized home isolation shall be implemented. Do not have the conditions of home isolation, should be centralized isolation.

Explanation: home isolation observation means that it is best to live alone; If conditions do not allow the choice, a well-ventilated room in a house should remain relatively independent as an isolation room, and it is best not to use air conditioning in the room, especially the central air conditioning shared with other rooms; If conditions permit, try to use a separate bathroom and avoid sharing it with other family members. This is home medical observation.

Those who stay at the airport for more than half an hour and enter the lobby but have not touched the public facilities inside the airport should be tested for nucleic acid three times a week according to the specifications. These three times of nucleic acid testing are also required, not three times in a row, but the interval between two times should exceed 24 hours, and three times of nucleic acid testing have been done in various ways, such as mixed sampling at 1: 5 or 1: 10, and the time interval can meet the requirements without re-testing. What about those who have been in contact with the airport? If you have touched it, you should observe it at home.

If you stop at the airport for a short time, within half an hour, and you don’t enter the airport lobby, such as giving someone away or passing by, you can turn it into a green code if the nucleic acid test is negative.

Those who pass through the airport by means of transportation and have never been to the airport can turn green after passing the big data screening. Because in high-risk areas, the degree of risk is still relatively large, and there are still risks, so everyone should be responsible for themselves and the society, and be realistic about their own situation.

As for how to decode these policies, the Nanjing area "Su Kang codeThe transcoding policy is based on the documents issued this time. You can learn how to do the specific transcoding through the 12345 government hotline, and there will be a corresponding team to do this, so as to provide you with a more convenient and convenient process.

Yesterday, the Center for Disease Control and Prevention in jianye district reported that a citizen’s initial screening result of nucleic acid test was positive (this citizen was engaged in ground work at Lukou Airport, and now he was diagnosed as an ordinary case and was treated in isolation in a designated hospital in Nanjing). jianye district immediately launched an emergency plan and took the following measures:

The first is to carry out flow adjustment and control personnel classification. As of 0: 00 today, through the flow adjustment, there are 44 close-contact and sub-close-contact personnel in jianye district, who have been transported in strict accordance with the protection regulations and concentrated on medical observation. All the secret and sub-secret personnel outside the area shall be notified to the local area for isolation management. There are 17 people in 8 households in the same unit of this person’s residence, and all of them are centralized and isolated according to the close contact personnel.

The second is to implement closed management of the community, and other people in the community conduct home health monitoring.

The third is to carry out nucleic acid sampling and testing. By the end of 0: 00, 1178 people were sampled from the close contact personnel, the sub-close contact personnel and the people in the residential area, and 46 samples were sampled from the environment such as the residence, corridor and elevator of this case. All the test results were negative.

The fourth is to carry out environmental disinfection. The residence, building and unit of the case were disinfected.

The fifth is to classify and deal with community garbage. The garbage generated by the case family and the protective articles used by the staff involved in closed management are treated as medical wastes; Other garbage generated by residents in the community will be collected and treated separately by special personnel every day.